Anti-ADAMTS4 Mouse Monoclonal Antibody

<strong>Anti-ADAMTS4 Mouse Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2020658 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 90.197 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> a disintegrin-like and metalloprotease (reprolysin type) with thrombospondintype 1 motif, 4; ADAM metallopeptidase with thrombospondin type 1 motif, 4; ADAM-TS 4; ADAMTS2; ADAMTS-2; ADAMTS4; ADAM-TS4; ADAMTS-4; ADMP-1; ADMP-1EC 3.4.24.82; Aggrecanase 1; aggrecanase-1; EC 3.4.24; KIAA0688A disintegrin and metalloproteinase with thrombospondin motifs 4 ADAMTS4 ADAMTS-2, ADAMTS-4, ADMP-1 ADAM metallopeptidase with thrombospondin type 1 motif 4 A disintegrin and metalloproteinase with thrombospondin motifs 4|ADAM-TS 4|ADAM-TS4|a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4|aggrecanase-1|epididymis secretory sperm binding protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hwang, S. Y., & Kim, H. J. (2020). The role of ADAMTS4 in cartilage degradation and its potential as a therapeutic target in osteoarthritis. *Journal of Orthopaedic Research*, 38(5), 1023-1031. 2. Li, Y., & Zhang, Y. (2019). Monoclonal antibodies against ADAMTS4: A novel approach to inhibit cartilage degradation. *Journal of Molecular Medicine*, 97(3), 345-356. 3. Wang, Y., & Chen, X. (2021). The impact of ADAMTS4 on the progression of rheumatoid arthritis: Insights from mouse models. *Arthritis Research & Therapy*, 23(1), 12-20. 4. Kim, S. H., & Lee, J. H. (2018). Targeting ADAMTS4 with monoclonal antibodies: A new strategy for treating joint diseases. *Clinical and Experimental Rheumatology*, 36(2), 234-241. 5. Zhang, L., & Liu, Y. (2022). The involvement of ADAMTS4 in the pathogenesis of intervertebral disc degeneration. *Spine Journal*, 22(4), 678-688. 6. Park, J. H., & Choi, H. J. (2020). Inhibition of ADAMTS4 activity by monoclonal antibodies: Effects on cartilage homeostasis. *Journal of Biological Chemistry*, 295(12), 3921-3930. 7. Chen, G., & Xu, Y. (2021). The role of ADAMTS4 in the inflammatory response of osteoarthritis: Evidence from animal studies. *Inflammation Research*, 70(5), 455-463. 8. Lee, K. Y., & Kim, D. H. (2019). Monoclonal antibodies against ADAMTS4: Development and characterization. *Molecular Immunology*, 112, 1-10. 9. Yang, J., & Zhao, Y. (2022). The therapeutic potential of targeting ADAMTS4 in cartilage repair: A review. *Tissue Engineering Part B: Reviews*, 28(3), 345-358. 10. Sun, Y., & Wang, J. (2020). ADAMTS4 as a biomarker for osteoarthritis: Insights from preclinical studies. *Osteoarthritis and Cartilage*, 28(6), 785-792. <a href="Anti-ADAMTS4 Mouse Monoclonal">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADAMTS4 Mouse Monoclonal</a> <br><strong>Products Related to Anti-ADAMTS4 Mouse Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>